AAPL311.09-2.30 (-0.73%) ▼|ABBV252.91+0.17 (+0.07%) ▲|ABT94.32-0.86 (-0.90%) ▼|ACN136.08+0.52 (+0.38%) ▲|ADBE220.08-0.86 (-0.39%) ▼|AMAT624.18+53.68 (+9.41%) ▲|AMD555.62+38.21 (+7.38%) ▲|AMGN363.52-4.47 (-1.21%) ▼|AMT164.97-0.08 (-0.05%) ▼|AMZN242.50-1.12 (-0.46%) ▼|AVGO394.69+6.00 (+1.54%) ▲|AXP339.78+3.39 (+1.01%) ▲|BA223.38-1.57 (-0.70%) ▼|BAC58.85+0.55 (+0.94%) ▲|BKNG171.91-2.39 (-1.37%) ▼|BLK1,005.39+15.05 (+1.52%) ▲|BMY57.56+0.02 (+0.03%) ▲|BNY154.34+4.20 (+2.79%) ▲|BRK-B494.90+0.11 (+0.02%) ▲|C138.69+1.30 (+0.95%) ▲|CAT965.45+17.37 (+1.83%) ▲|CL92.11-0.93 (-1.00%) ▼|CMCSA22.91-0.29 (-1.23%) ▼|COF196.17+4.22 (+2.20%) ▲|COP108.96-1.76 (-1.59%) ▼|COST916.07-37.06 (-3.89%) ▼|CRM162.26-4.32 (-2.59%) ▼|CSCO117.31+3.49 (+3.07%) ▲|CVS104.47+0.00 (+0.00%) ▲|CVX174.69-1.29 (-0.73%) ▼|DE600.75+4.01 (+0.67%) ▲|DHR192.54+1.77 (+0.93%) ▲|DIS95.13-1.57 (-1.62%) ▼|DUK125.93-0.87 (-0.68%) ▼|EMR138.70+2.22 (+1.63%) ▲|FDX316.81+7.05 (+2.27%) ▲|GD370.82-3.49 (-0.93%) ▼|GE358.29+2.26 (+0.63%) ▲|GEV1,082.18+11.19 (+1.04%) ▲|GILD135.04-0.78 (-0.57%) ▼|GM76.09-0.15 (-0.20%) ▼|GOOG351.85-6.86 (-1.91%) ▼|GOOGL354.36-7.57 (-2.09%) ▼|GS1,056.30+26.66 (+2.59%) ▲|HD338.14+1.93 (+0.57%) ▲|HON218.35-2.01 (-0.91%) ▼|IBM296.26-5.79 (-1.92%) ▼|INTC115.63+5.39 (+4.89%) ▲|INTU269.41-2.70 (-0.99%) ▼|ISRG413.46-1.65 (-0.40%) ▼|JNJ261.68-1.73 (-0.65%) ▼|JPM333.93+3.31 (+1.00%) ▲|KO81.97-1.43 (-1.71%) ▼|LIN520.79-6.88 (-1.30%) ▼|LLY1,214.08-1.75 (-0.14%) ▼|LMT518.41-9.55 (-1.81%) ▼|LOW213.18+0.33 (+0.16%) ▲|LRCX364.72+31.57 (+9.48%) ▲|MA520.99+2.00 (+0.38%) ▲|MCD274.13-4.12 (-1.48%) ▼|MDLZ58.56-0.93 (-1.56%) ▼|MDT82.15+0.14 (+0.16%) ▲|META597.76-5.36 (-0.89%) ▼|MMM155.80+1.10 (+0.71%) ▲|MO72.88+0.07 (+0.10%) ▲|MRK125.36-0.64 (-0.50%) ▼|MS222.67+4.60 (+2.11%) ▲|MSFT377.70-5.64 (-1.47%) ▼|MU1,028.89+80.09 (+8.44%) ▲|NEE87.03-0.41 (-0.47%) ▼|NFLX75.36-0.23 (-0.30%) ▼|NKE42.49-0.41 (-0.94%) ▼|NOW106.82-0.96 (-0.89%) ▼|NVDA200.95-3.17 (-1.55%) ▼|ORCL148.02+7.53 (+5.36%) ▲|PEP134.93-7.57 (-5.31%) ▼|PFE24.20+0.15 (+0.62%) ▲|PG146.28-2.12 (-1.43%) ▼|PLTR128.52-3.70 (-2.80%) ▼|PM185.67-1.41 (-0.75%) ▼|QCOM191.21+4.65 (+2.49%) ▲|RTX194.58-0.33 (-0.17%) ▼|SBUX105.96+2.09 (+2.01%) ▲|SCHW102.16+0.46 (+0.45%) ▲|SO95.79-0.59 (-0.61%) ▼|SPG219.92+0.83 (+0.38%) ▲|T20.94-0.19 (-0.88%) ▼|TMO513.00+2.87 (+0.56%) ▲|TMUS179.06-1.09 (-0.60%) ▼|TSLA397.95+4.02 (+1.02%) ▲|TXN310.53+9.21 (+3.06%) ▲|UBER73.30-0.31 (-0.41%) ▼|UNH433.58+7.98 (+1.88%) ▲|UNP282.92+1.98 (+0.70%) ▲|UPS111.28+1.34 (+1.22%) ▲|USB61.41+0.41 (+0.66%) ▲|V347.26-0.27 (-0.08%) ▼|VZ41.95-0.50 (-1.18%) ▼|WFC85.99+0.43 (+0.50%) ▲|WMT111.87-1.24 (-1.09%) ▼|XOM138.51-2.63 (-1.86%) ▼|AAPL311.09-2.30 (-0.73%) ▼|ABBV252.91+0.17 (+0.07%) ▲|ABT94.32-0.86 (-0.90%) ▼|ACN136.08+0.52 (+0.38%) ▲|ADBE220.08-0.86 (-0.39%) ▼|AMAT624.18+53.68 (+9.41%) ▲|AMD555.62+38.21 (+7.38%) ▲|AMGN363.52-4.47 (-1.21%) ▼|AMT164.97-0.08 (-0.05%) ▼|AMZN242.50-1.12 (-0.46%) ▼|AVGO394.69+6.00 (+1.54%) ▲|AXP339.78+3.39 (+1.01%) ▲|BA223.38-1.57 (-0.70%) ▼|BAC58.85+0.55 (+0.94%) ▲|BKNG171.91-2.39 (-1.37%) ▼|BLK1,005.39+15.05 (+1.52%) ▲|BMY57.56+0.02 (+0.03%) ▲|BNY154.34+4.20 (+2.79%) ▲|BRK-B494.90+0.11 (+0.02%) ▲|C138.69+1.30 (+0.95%) ▲|CAT965.45+17.37 (+1.83%) ▲|CL92.11-0.93 (-1.00%) ▼|CMCSA22.91-0.29 (-1.23%) ▼|COF196.17+4.22 (+2.20%) ▲|COP108.96-1.76 (-1.59%) ▼|COST916.07-37.06 (-3.89%) ▼|CRM162.26-4.32 (-2.59%) ▼|CSCO117.31+3.49 (+3.07%) ▲|CVS104.47+0.00 (+0.00%) ▲|CVX174.69-1.29 (-0.73%) ▼|DE600.75+4.01 (+0.67%) ▲|DHR192.54+1.77 (+0.93%) ▲|DIS95.13-1.57 (-1.62%) ▼|DUK125.93-0.87 (-0.68%) ▼|EMR138.70+2.22 (+1.63%) ▲|FDX316.81+7.05 (+2.27%) ▲|GD370.82-3.49 (-0.93%) ▼|GE358.29+2.26 (+0.63%) ▲|GEV1,082.18+11.19 (+1.04%) ▲|GILD135.04-0.78 (-0.57%) ▼|GM76.09-0.15 (-0.20%) ▼|GOOG351.85-6.86 (-1.91%) ▼|GOOGL354.36-7.57 (-2.09%) ▼|GS1,056.30+26.66 (+2.59%) ▲|HD338.14+1.93 (+0.57%) ▲|HON218.35-2.01 (-0.91%) ▼|IBM296.26-5.79 (-1.92%) ▼|INTC115.63+5.39 (+4.89%) ▲|INTU269.41-2.70 (-0.99%) ▼|ISRG413.46-1.65 (-0.40%) ▼|JNJ261.68-1.73 (-0.65%) ▼|JPM333.93+3.31 (+1.00%) ▲|KO81.97-1.43 (-1.71%) ▼|LIN520.79-6.88 (-1.30%) ▼|LLY1,214.08-1.75 (-0.14%) ▼|LMT518.41-9.55 (-1.81%) ▼|LOW213.18+0.33 (+0.16%) ▲|LRCX364.72+31.57 (+9.48%) ▲|MA520.99+2.00 (+0.38%) ▲|MCD274.13-4.12 (-1.48%) ▼|MDLZ58.56-0.93 (-1.56%) ▼|MDT82.15+0.14 (+0.16%) ▲|META597.76-5.36 (-0.89%) ▼|MMM155.80+1.10 (+0.71%) ▲|MO72.88+0.07 (+0.10%) ▲|MRK125.36-0.64 (-0.50%) ▼|MS222.67+4.60 (+2.11%) ▲|MSFT377.70-5.64 (-1.47%) ▼|MU1,028.89+80.09 (+8.44%) ▲|NEE87.03-0.41 (-0.47%) ▼|NFLX75.36-0.23 (-0.30%) ▼|NKE42.49-0.41 (-0.94%) ▼|NOW106.82-0.96 (-0.89%) ▼|NVDA200.95-3.17 (-1.55%) ▼|ORCL148.02+7.53 (+5.36%) ▲|PEP134.93-7.57 (-5.31%) ▼|PFE24.20+0.15 (+0.62%) ▲|PG146.28-2.12 (-1.43%) ▼|PLTR128.52-3.70 (-2.80%) ▼|PM185.67-1.41 (-0.75%) ▼|QCOM191.21+4.65 (+2.49%) ▲|RTX194.58-0.33 (-0.17%) ▼|SBUX105.96+2.09 (+2.01%) ▲|SCHW102.16+0.46 (+0.45%) ▲|SO95.79-0.59 (-0.61%) ▼|SPG219.92+0.83 (+0.38%) ▲|T20.94-0.19 (-0.88%) ▼|TMO513.00+2.87 (+0.56%) ▲|TMUS179.06-1.09 (-0.60%) ▼|TSLA397.95+4.02 (+1.02%) ▲|TXN310.53+9.21 (+3.06%) ▲|UBER73.30-0.31 (-0.41%) ▼|UNH433.58+7.98 (+1.88%) ▲|UNP282.92+1.98 (+0.70%) ▲|UPS111.28+1.34 (+1.22%) ▲|USB61.41+0.41 (+0.66%) ▲|V347.26-0.27 (-0.08%) ▼|VZ41.95-0.50 (-1.18%) ▼|WFC85.99+0.43 (+0.50%) ▲|WMT111.87-1.24 (-1.09%) ▼|XOM138.51-2.63 (-1.86%) ▼|
28.1 C
New York
Thursday, July 9, 2026

Tag: innovation

newssourceFORcompanyinformationcontent1releasesmarket

Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke

SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Zusammenarbeit zwischen Patienten und Ärzten fördert, um fundierte, individuelle Gesundheitsentscheidungen zu ermöglichen, hat heute einen bedeutenden Meilenstein in seiner Expansion in Europa bekanntgegeben: die Einführung von drei neuen medizinischen Cannabissorten in Italien. Über seine hundertprozentige Tochtergesellschaft FL Group ist Tilray das erste Unternehmen in Italien, das vom italienischen Gesundheitsministerium (Ministero della Salute) die offizielle Genehmigung für den Import und Vertrieb von medizinischem Cannabisblüten der Marke Tilray Medical für therapeutische Zwecke erhalten hat.

BloodVitals Pain-Free Blood Glucose Monitoring Device Launches to Support At-Home Wellness Tracking

Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools. 
Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.

Kia President and CEO Ho Sung Song honored at 2025 Autocar Awards

-  President and CEO Ho Sung Song awarded with Autocar's highest accolade, the Issigonis Trophy, in recognition of his significant contributions to the global...

Glokore Light Therapy Mask Earns Spotlight as Non-Invasive Red Light Skincare Solution Backed by User Satisfaction

LED-Based Skincare Device Highlighted for Non-Invasive Anti-Aging and Acne Support Backed by Clinical Usage Data 
LED-Based Skincare Device Highlighted for Non-Invasive Anti-Aging and Acne Support Backed by Clinical Usage Data

Zymo Research Unveils MultiOmiX Workstation with Show-Stopping Launch at ASM Microbe 2025

IRVINE, Calif., June 24, 2025 /PRNewswire/ -- Zymo Research stole the spotlight at the American Society for Microbiology (ASM) Microbe 2025 conference with the official...

Kia President and CEO Ho Sung Song honored at 2025 Autocar Awards

-  President and CEO Ho Sung Song awarded with Autocar's highest accolade, the Issigonis Trophy, in recognition of his significant contributions to the global...

House of Sillage Unveils “Superman”—A Fragrance that Honors the Duality of a Hero

House of Sillage releases the new Superman Fragrance in collaboration with WBDGCP to celebrate the upcoming film Superman, directed by James Gunn.

RBLP Leadership Certifications Receive Prestigious American Council on Education (ACE) College Credit Recommendations

BURBANK, Calif., June 24, 2025 /PRNewswire/ -- The Resilience-Building Leader Program (RBLP) proudly announces that its RBLP Leadership Certifications have been awarded college credit...

Kia President and CEO Ho Sung Song honored at 2025 Autocar Awards

-  President and CEO Ho Sung Song awarded with Autocar's highest accolade, the Issigonis Trophy, in recognition of his significant contributions to the global...

Kia President and CEO Ho Sung Song honored at 2025 Autocar Awards

-  President and CEO Ho Sung Song awarded with Autocar's highest accolade, the Issigonis Trophy, in recognition of his significant contributions to the global...

Kia President and CEO Ho Sung Song honored at 2025 Autocar Awards

-  President and CEO Ho Sung Song awarded with Autocar's highest accolade, the Issigonis Trophy, in recognition of his significant contributions to the global...

Melcor announces election of directors

EDMONTON, Alberta, June 24, 2025 (GLOBE NEWSWIRE) -- Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset management company, announced the results of its annual general meeting (AGM), held today. A total of 24,073,887 shares were voted in person or by proxy, representing 79.59% of the outstanding shares as of the record date. Shareholders approved all items of business before the AGM, including the election of directors as follows:

BAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsight

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),...

BAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsight

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInnovation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers